Related references
Note: Only part of the references are listed.MicroRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepato-cellular Carcinoma
Seyed Mostafa Parizadeh et al.
CURRENT DRUG TARGETS (2019)
Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer
Andrew E. Blum et al.
GASTROENTEROLOGY (2019)
Assessment of miR-98-5p, miR-152-3p, miR-326 and miR-4289 Expression as Biomarker for Prostate Cancer Diagnosis
Leire Moya et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
miR-505 acts as a tumor suppressor in gastric cancer progression through targeting HMGB1
Liang Tian et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance
Ning Wang et al.
CANCERS (2019)
miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions
Chih-Hung Chou et al.
NUCLEIC ACIDS RESEARCH (2018)
microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients
Luigi Mari et al.
GASTROENTEROLOGY (2018)
Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett's Esophagus
Xiaodun Li et al.
GASTROENTEROLOGY (2018)
Hsa-let-7b inhibits cell proliferation by targeting PLK1 in HCC
Zili He et al.
GENE (2018)
Role of Forkhead Box Class O proteins in cancer progression and metastasis
Chang Geun Kim et al.
SEMINARS IN CANCER BIOLOGY (2018)
MicroRNA-425 promotes the development of lung adenocarcinoma via targeting A disintegrin and metalloproteinases 9 (ADAM9)
Ruibao Liu et al.
ONCOTARGETS AND THERAPY (2018)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2018)
Identifying a miRNA signature for predicting the stage of breast cancer
Srinivasulu Yerukala Sathipati et al.
SCIENTIFIC REPORTS (2018)
miR-424 targets AKT3 and PSAT1 and has a tumor-suppressive role in human colorectal cancer
Yifeng Fang et al.
CANCER MANAGEMENT AND RESEARCH (2018)
miR-424 coordinates multilayered regulation of cell cycle progression to promote esophageal squamous cell carcinoma cell proliferation
Jing Wen et al.
EBIOMEDICINE (2018)
miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway
Wei Sun et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression
Yan Wang et al.
ANNALS OF SURGERY (2016)
The roles of the Hippo pathway in cancer metastasis
Helena J. Janse van Rensburg et al.
CELLULAR SIGNALLING (2016)
MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmil, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions
Bonnie Choy et al.
HUMAN PATHOLOGY (2016)
MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α
Shuo Chen et al.
MOLECULAR CANCER (2016)
Let-7b inhibits cell proliferation, migration, and invasion through targeting Cthrc1 in gastric cancer
Junbo Yu et al.
TUMOR BIOLOGY (2015)
Let-7b-5p regulates proliferation and apoptosis in multiple myeloma by targeting IGF1R
Honghai Xu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2014)
A Validated miRNA Profile Predicts Response to Therapy in Esophageal Adenocarcinoma
Heath D. Skinner et al.
CANCER (2014)
Predictive Value of MicroRNAs in the Progression of Barrett Esophagus to Adenocarcinoma in a Long-Term Follow-up Study
Beatriz Revilla-Nuin et al.
ANNALS OF SURGERY (2013)
MiR-26a regulates cell cycle and anoikis of human esophageal adenocarcinoma cells through Rb1-E2F1 signaling pathway
Ya-Fei Zhang et al.
MOLECULAR BIOLOGY REPORTS (2013)
The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends
A. P. Thrift et al.
ANNALS OF ONCOLOGY (2012)
The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis
Rom S. Leidner et al.
GENES CHROMOSOMES & CANCER (2012)
Defining Cure for Esophageal Cancer: Analysis of Actual 5-Year Survivors Following Esophagectomy
Jodi Hirst et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
MicroRNA Prognostic Signature for Nodal Metastases and Survival in Esophageal Adenocarcinoma
Andrew Feber et al.
ANNALS OF THORACIC SURGERY (2011)
Inflammatory and MicroRNA Gene Expression as Prognostic Classifier of Barrett's-Associated Esophageal Adenocarcinoma
Giang Huong Nguyen et al.
CLINICAL CANCER RESEARCH (2010)
The widespread regulation of microRNA biogenesis, function and decay
Jacek Krol et al.
NATURE REVIEWS GENETICS (2010)
Sparse kernel learning with LASSO and Bayesian inference algorithm
Junbin Gao et al.
NEURAL NETWORKS (2010)
MicroRNA-196a Is a Potential Marker of Progression during Barrett's Metaplasia-Dysplasia-Invasive Adenocarcinoma Sequence in Esophagus
Dipen M. Maru et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
The Mcm2-7 complex has in vitro helicase activity
Matthew L. Bochman et al.
MOLECULAR CELL (2008)
Orc6 is required for dynamic recruitment of Cdt1 during repeated Mcm2-7 loading
Shuyan Chen et al.
GENES & DEVELOPMENT (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Uninterrupted MCM2-7 function required for DNA replication fork progression
K Labib et al.
SCIENCE (2000)
Share Paper
